Contraceptive prevalence, any modern method in Madagascar
Madagascar: Contraceptive prevalence, any modern method was 34.1% in 2021. ◆ Volatile
Contraceptive prevalence, any modern method in Madagascar, 1992–2021
Source: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of all women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Madagascar is 34.1%, measured in 2021. That is the highest value across all 8 years on record.
Compared with earlier readings it is up 3.1% on the previous year and up 48.3% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Madagascar peaked at 34.1% in 2021 and was at its lowest, 3.5%, in 1992.
That places Madagascar 30th out of 62 countries with data for 2021, putting it in the middle of the range.
Contraceptive prevalence, any modern method in Madagascar, year by year
| Year | % of all women ages 15-49 | Change |
|---|---|---|
| 1992 | 3.5% | — |
| 1997 | 7.3% | +108.6% |
| 2004 | 14.0% | +91.8% |
| 2009 | 23.0% | +64.3% |
| 2013 | 26.9% | +17.0% |
| 2017 | 33.1% | +23.0% |
| 2018 | 33.1% | -0.1% |
| 2021 | 34.1% | +3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 5.4% | 3.5% | 7.3% | 2 |
| 2000s | 18.5% | 14.0% | 23.0% | 2 |
| 2010s | 31.0% | 26.9% | 33.1% | 3 |
| 2020s | 34.1% | 34.1% | 34.1% | 1 |
Countries ranked near Madagascar
More health data for Madagascar
- Un projection of annual infant deaths, annual growth rate -1.87 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4912 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 920.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,569 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 63 (2025)
- Population ages 00-04, female, annual growth rate 1.32 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.071 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.3 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Madagascar?
- Contraceptive prevalence, any modern method in Madagascar was 34.1% in 2021, according to Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Madagascar?
- The highest recorded value was 34.1% in 2021.
- What is the lowest contraceptive prevalence, any modern method recorded in Madagascar?
- The lowest recorded value was 3.5% in 1992.
- How does Madagascar rank for contraceptive prevalence, any modern method?
- Madagascar ranks 30th out of 62 countries with data for 2021.
- Is contraceptive prevalence, any modern method rising or falling in Madagascar?
- Over the last ten years it is up 48.3%. The long-run trend across the full record is volatile.
- Where does this Madagascar data come from?
- The figures come from Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.